Salvage Chemotherapy Versus Total Mesorectal Resection for Local Resection Rectal Cancer Patients
Conditions:   Chemotherapy Effect;   Rectal Cancer Interventions:   Procedure: Radical total mesorectal excision;   Other: Salavge Adjuvant Chemoradiotherapy Sponsor:   Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

Preoperative FOLFOXIRI Chemotherapy Combined With Lateral Lymph Node Dissection in Rectal Cancer
Conditions:   Lymph Node Metastasis;   Cancer of Rectum and Anus;   Oxaliplatin;   Intestinal Neoplasms;   Gastrointestinal Neoplasms;   Rectal Diseases;   Rectal Neoplasms Interventions:   Drug: Experimental: FOLFOXIRI and Lateral lymph node dissection;   Drug: Preoperative long-term concurrent chemoradiotherapy and Lateral lymph node dissection Sponsor:   Cancer Institute and Hospital, Chinese Academy of Medical Sciences Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

Salvage Chemotherapy Versus Total Mesorectal Resection for Local Resection Rectal Cancer Patients
Conditions:   Chemotherapy Effect;   Rectal Cancer Interventions:   Procedure: Radical total mesorectal excision;   Other: Salavge Adjuvant Chemoradiotherapy Sponsor:   Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

Preoperative FOLFOXIRI Chemotherapy Combined With Lateral Lymph Node Dissection in Rectal Cancer
Conditions:   Lymph Node Metastasis;   Cancer of Rectum and Anus;   Oxaliplatin;   Intestinal Neoplasms;   Gastrointestinal Neoplasms;   Rectal Diseases;   Rectal Neoplasms Interventions:   Drug: Experimental: FOLFOXIRI and Lateral lymph node dissection;   Drug: Preoperative long-term concurrent chemoradiotherapy and Lateral lymph node dissection Sponsor:   Cancer Institute and Hospital, Chinese Academy of Medical Sciences Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

Salvage Chemotherapy Versus Total Mesorectal Resection for Local Resection Rectal Cancer Patients
Conditions:   Chemotherapy Effect;   Rectal Cancer Interventions:   Procedure: Radical total mesorectal excision;   Other: Salavge Adjuvant Chemoradiotherapy Sponsor:   Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

Preoperative FOLFOXIRI Chemotherapy Combined With Lateral Lymph Node Dissection in Rectal Cancer
Conditions:   Lymph Node Metastasis;   Cancer of Rectum and Anus;   Oxaliplatin;   Intestinal Neoplasms;   Gastrointestinal Neoplasms;   Rectal Diseases;   Rectal Neoplasms Interventions:   Drug: Experimental: FOLFOXIRI and Lateral lymph node dissection;   Drug: Preoperative long-term concurrent chemoradiotherapy and Lateral lymph node dissection Sponsor:   Cancer Institute and Hospital, Chinese Academy of Medical Sciences Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

Salvage Chemotherapy Versus Total Mesorectal Resection for Local Resection Rectal Cancer Patients
Conditions:   Chemotherapy Effect;   Rectal Cancer Interventions:   Procedure: Radical total mesorectal excision;   Other: Salavge Adjuvant Chemoradiotherapy Sponsor:   Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

Preoperative FOLFOXIRI Chemotherapy Combined With Lateral Lymph Node Dissection in Rectal Cancer
Conditions:   Lymph Node Metastasis;   Cancer of Rectum and Anus;   Oxaliplatin;   Intestinal Neoplasms;   Gastrointestinal Neoplasms;   Rectal Diseases;   Rectal Neoplasms Interventions:   Drug: Experimental: FOLFOXIRI and Lateral lymph node dissection;   Drug: Preoperative long-term concurrent chemoradiotherapy and Lateral lymph node dissection Sponsor:   Cancer Institute and Hospital, Chinese Academy of Medical Sciences Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

Salvage Chemotherapy Versus Total Mesorectal Resection for Local Resection Rectal Cancer Patients
Conditions:   Chemotherapy Effect;   Rectal Cancer Interventions:   Procedure: Radical total mesorectal excision;   Other: Salavge Adjuvant Chemoradiotherapy Sponsor:   Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

Preoperative FOLFOXIRI Chemotherapy Combined With Lateral Lymph Node Dissection in Rectal Cancer
Conditions:   Lymph Node Metastasis;   Cancer of Rectum and Anus;   Oxaliplatin;   Intestinal Neoplasms;   Gastrointestinal Neoplasms;   Rectal Diseases;   Rectal Neoplasms Interventions:   Drug: Experimental: FOLFOXIRI and Lateral lymph node dissection;   Drug: Preoperative long-term concurrent chemoradiotherapy and Lateral lymph node dissection Sponsor:   Cancer Institute and Hospital, Chinese Academy of Medical Sciences Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

Salvage Chemotherapy Versus Total Mesorectal Resection for Local Resection Rectal Cancer Patients
Conditions:   Chemotherapy Effect;   Rectal Cancer Interventions:   Procedure: Radical total mesorectal excision;   Other: Salavge Adjuvant Chemoradiotherapy Sponsor:   Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

Preoperative FOLFOXIRI Chemotherapy Combined With Lateral Lymph Node Dissection in Rectal Cancer
Conditions: Lymph Node Metastasis; Cancer of Rectum and Anus; Oxaliplatin; Intestinal Neoplasms; Gastrointestinal Neoplasms; Rectal Diseases; Rectal Neoplasms Interventions: Drug: Experimental: FOLFOXIRI and Lateral lymph node dissection; Drug: Preoperative long-term concurrent chemoradiotherapy and Lateral lymph node dissection Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

Can we Use a Simple Blood Test to Reduce Unnecessary Adverse Effects From Radiotherapy by Timely Identification of Radiotherapy-resistant Rectal Cancers? MeD-Seq Rectal Study
Condition:   Pathological Response Rate, Circulating Tumour DNA Intervention:   Diagnostic Test: MeD-seq Sponsor:   Erasmus Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

Treatment of Low Locally Advanced Rectal Cancer With Radiotherapy Removal TNT Plus Neoadjuvant Therapy
Condition:   Rectal Cancer Interventions:   Drug: CapeOX + cetuximab;   Drug: CapeOX + bevacizumab;   Radiation: radiotherapy Sponsor:   Tang-Du Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

Can we Use a Simple Blood Test to Reduce Unnecessary Adverse Effects From Radiotherapy by Timely Identification of Radiotherapy-resistant Rectal Cancers? MeD-Seq Rectal Study
Condition:   Pathological Response Rate, Circulating Tumour DNA Intervention:   Diagnostic Test: MeD-seq Sponsor:   Erasmus Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials